• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 04, 2023 at 04:32: PM
via As doctors weigh various immunotherapy strategies for the treatment of early-stage non-small cell lung cancer, Merck & Co. has now unveiled new data that it hopes can establish Keytruda, used both before and after surgery, as a new standard of care.

article source
 




Top Bottom
Back
Quote